1. Identification of a Novel EIF2AK Variant and Genetics-Assisted Approach to Diagnosis of Pulmonary Capillary Hemangiomatosis.
- Author
-
Kimmig LM, Stutz MR, Husain AN, and Bag R
- Subjects
- Humans, Lung diagnostic imaging, Lung pathology, Lung surgery, Protein Serine-Threonine Kinases, Hemangioma, Capillary diagnosis, Hemangioma, Capillary genetics, Hemangioma, Capillary pathology, Hypertension, Pulmonary diagnosis, Hypertension, Pulmonary genetics, Lung Diseases, Pulmonary Veno-Occlusive Disease diagnosis, Pulmonary Veno-Occlusive Disease genetics, Pulmonary Veno-Occlusive Disease pathology
- Abstract
Pulmonary capillary hemangiomatosis (PCH) is an uncommon type of pulmonary vascular disease characterized by capillary proliferation and very poor prognosis owing to misdiagnosis and lack of effective therapeutic options. Mutations in the eukaryotic translation initiation factor 2α kinase 4 (EIF2AK4) gene have been reported in pulmonary veno-occlusive disease and PCH. In this report, we present a patient whose diagnosis of PCH was delayed by 2 ½ years despite prior surgical lung biopsy and clinical and laboratory findings suggestive of pulmonary hypertension. Genotyping revealed a novel likely pathogenic variant in the EIF2AK4 gene. Review of surgical lung biopsy performed 2 ½ years prior confirmed PCH histology along with constrictive bronchiolitis., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF